Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Trypanosoma cruzi | trypanothione reductase, putative | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | trypanothione reductase, putative | 492 aa | 548 aa | 21.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | glutathione reductase | 0.0076 | 0.0183 | 0.0183 |
Mycobacterium ulcerans | hypothetical protein | 0.2743 | 1 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0076 | 0.0183 | 0.0312 |
Echinococcus multilocularis | synaptic glycoprotein sc2 | 0.1622 | 0.5875 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0026 | 0 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.2743 | 1 | 1 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1622 | 0.5875 | 0.5875 |
Loa Loa (eye worm) | hypothetical protein | 0.1622 | 0.5875 | 0.5798 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0076 | 0.0183 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0026 | 0 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.1622 | 0.5875 | 0.5875 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0076 | 0.0183 | 0.0312 |
Brugia malayi | Thioredoxin reductase | 0.0076 | 0.0183 | 0.0183 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.2743 | 1 | 1 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.1622 | 0.5875 | 0.5875 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1622 | 0.5875 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.2743 | 1 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0076 | 0.0183 | 0.0312 |
Onchocerca volvulus | 0.1622 | 0.5875 | 0.5 | |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.1622 | 0.5875 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1622 | 0.5875 | 0.5875 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.1622 | 0.5875 | 1 |
Echinococcus granulosus | 3 oxo 5 alpha steroid 4 dehydrogenase C terminal | 0.1622 | 0.5875 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.2743 | 1 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0076 | 0.0183 | 0.0312 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1622 | 0.5875 | 0.5875 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.1622 | 0.5875 | 0.5875 |
Plasmodium falciparum | glutathione reductase | 0.0076 | 0.0183 | 0.0312 |
Trypanosoma brucei | trypanothione reductase | 0.0076 | 0.0183 | 0.0183 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.1622 | 0.5875 | 1 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.1622 | 0.5875 | 0.5875 |
Loa Loa (eye worm) | hypothetical protein | 0.1622 | 0.5875 | 0.5798 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1622 | 0.5875 | 0.5875 |
Leishmania major | trypanothione reductase | 0.0076 | 0.0183 | 0.0183 |
Toxoplasma gondii | thioredoxin reductase | 0.0076 | 0.0183 | 0.0183 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0026 | 0 | 0.5 |
Echinococcus multilocularis | 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal | 0.1622 | 0.5875 | 1 |
Plasmodium vivax | polyprenol reductase, putative | 0.1622 | 0.5875 | 1 |
Echinococcus granulosus | synaptic glycoprotein sc2 | 0.1622 | 0.5875 | 1 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.1622 | 0.5875 | 0.5875 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.2743 | 1 | 1 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.2743 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2743 | 1 | 1 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1622 | 0.5875 | 1 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative | 0.2743 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0076 | 0.0183 | 0.0312 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1622 | 0.5875 | 0.5875 |
Plasmodium falciparum | polyprenol reductase, putative | 0.1622 | 0.5875 | 1 |
Brugia malayi | Synaptic glycoprotein SC2 | 0.1622 | 0.5875 | 0.5875 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.2743 | 1 | 1 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.2743 | 1 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0076 | 0.0183 | 0.0183 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0026 | 0 | 0.5 |
Treponema pallidum | NADH oxidase | 0.0026 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 5.3 uM | Linear competitive inhibition of trypanothione reductase from Trypanosoma cruzi using (ZCG.dmapa)2 substrate | ChEMBL. | 16335933 |
Ki (binding) | = 5.3 uM | Linear competitive inhibition of trypanothione reductase from Trypanosoma cruzi using (ZCG.dmapa)2 substrate | ChEMBL. | 16335933 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.